Well Told Grants

Federal grant recipients / Massachusetts

Federal grants to Extend Biosciences Inc

Newton, Massachusetts · Small businesses · UEI DZTKWESJQQ99

Extend Biosciences Inc in Newton, Massachusetts received $5.8 million in federal grants from fiscal 2021 to 2025, across 3 awards. Its largest program was Diabetes, Digestive, and Kidney Diseases Extramural Research, with $4.0 million. In fiscal 2025 it was awarded $1.9 million.

From USAspending.gov award records, updated October 31, 2026.

By year

Federal grants to Extend Biosciences Inc by fiscal year
Fiscal yearAwardsAmount
FY 20211$2.0 million
FY 20220$0
FY 20231$899,808
FY 20241$999,615
FY 20252$1.9 million

An award funded in several years counts in each of them, so yearly awards add up to more than the five-year total.

Programs that fund Extend Biosciences Inc

Every program, fiscal 2021 to 2025
ProgramAwardsAmount
Diabetes, Digestive, and Kidney Diseases Extramural Research 93.8472$4.0 million
Food and Drug Administration Research 93.1031$1.8 million

Awarding agencies

AgencyAwardsAmount
Department of Health and Human Services3$5.8 million

Largest awards

The 3 largest awards by money obligated in fiscal 2021 to 2025
AwardProgramFirst actionAmount
Long-acting pth for hypoparathyroidism
ASST_NON_R44DK107231_075 on USAspending
Diabetes, Digestive, and Kidney Diseases Extramural ResearchMarch 25, 2021$2.0 million
Long-acting pth for hypoparathyroidism - project summary hypoparathyroidism is a rare disease that results from a deficiency or inability to make sufficient amounts of parathyroid hormone (PTH). Untreated or inadequately treated hypoparathyroidism leads to clinically significant mineral-related meta
ASST_NON_R44DK138647_075 on USAspending
Diabetes, Digestive, and Kidney Diseases Extramural ResearchAugust 29, 2024$2.0 million
A phase 2 study investigating the safety, tolerability and efficacy of EXT608 in adults with hypoparathyroidism (IND146180; october 14, 2022) - project summary hypoparathyroidism is a rare disease that results from a deficiency or inability to make sufficient amounts of parathyroid hormone (PTH). Un
ASST_NON_R01FD007824_075 on USAspending
Food and Drug Administration ResearchSeptember 20, 2023$1.8 million

Amounts are net obligations: money committed, minus any amounts taken back. They are not payments. See how our data works.

Questions people ask

How much federal grant money does Extend Biosciences Inc get?

$5.8 million in 3 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.

Which agency gives Extend Biosciences Inc the most?

The Department of Health and Human Services, with $5.8 million in 3 awards.

What is Extend Biosciences Inc's largest federal grant?

$2.0 million under Diabetes, Digestive, and Kidney Diseases Extramural Research, with its first action in the period on March 25, 2021. That counts only the money obligated in fiscal 2021 to 2025.

Which federal programs fund Extend Biosciences Inc?

Its largest are Diabetes, Digestive, and Kidney Diseases Extramural Research and Food and Drug Administration Research.

Other grant recipients in Newton

Largest federal grant recipients in Massachusetts · Federal grants in Massachusetts